Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greta Carioli

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
European Journal of Internal Medicine|August 8, 2024
Prognostic role of gait speed in worsening heart failureCamilla Cirelli, Raul Limonta, Greta Carioli, et al.
JHEP Reports : Innovation in Hepatology|March 27, 2025
Real-world experience with odevixibat in children with progressive familial intrahepatic cholestasisAngelo Di Giorgio, Marco Sciveres, Maurizio Fuoti, et al.
International Journal of Cardiology. Heart & Vasculature|July 25, 2022
Adherence of ticagrelOr in real world patients with aCute coronary syndrome: The AD-HOC studyLuigi Fiocca, Roberta Rossini, Greta Carioli, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|October 29, 2024
Respiratory rate-oxygenation index on the 3<sup>rd</sup> day is the best predictor of treatment failure in COVID-19 patientsFederico Raimondi, Stefano Centanni, Fabrizio Luppi, et al.
Endocrine|September 2, 2020
Risk factors for pancreas and lung neuroendocrine neoplasms: a case-control studyLuca Giraldi, Alessia Vecchioni, Greta Carioli, et al.
Respiratory Medicine and Research|December 6, 2022
One-year mortality in COVID-19 is associated with patients' comorbidities rather than pneumonia severityLuca Novelli, Federico Raimondi, Greta Carioli, et al.
NEJM Evidence|February 6, 2024
Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia VeraTiziano Barbui, Alessandro Maria Vannucchi, Valerio De Stefano, et al.
Annals of Hematology|December 7, 2023
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomesTiziano Barbui, Alessandra Carobbio, Valerio De Stefano, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 21, 2021
Coffee consumption and gastric cancer: a pooled analysis from the Stomach cancer Pooling Project consortiumGeorgia Martimianaki, Paola Bertuccio, Gianfranco Alicandro, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
European Journal of Internal Medicine|August 8, 2024
Prognostic role of gait speed in worsening heart failureCamilla Cirelli, Raul Limonta, Greta Carioli, et al.
JHEP Reports : Innovation in Hepatology|March 27, 2025
Real-world experience with odevixibat in children with progressive familial intrahepatic cholestasisAngelo Di Giorgio, Marco Sciveres, Maurizio Fuoti, et al.
International Journal of Cardiology. Heart & Vasculature|July 25, 2022
Adherence of ticagrelOr in real world patients with aCute coronary syndrome: The AD-HOC studyLuigi Fiocca, Roberta Rossini, Greta Carioli, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|October 29, 2024
Respiratory rate-oxygenation index on the 3<sup>rd</sup> day is the best predictor of treatment failure in COVID-19 patientsFederico Raimondi, Stefano Centanni, Fabrizio Luppi, et al.
Endocrine|September 2, 2020
Risk factors for pancreas and lung neuroendocrine neoplasms: a case-control studyLuca Giraldi, Alessia Vecchioni, Greta Carioli, et al.
Respiratory Medicine and Research|December 6, 2022
One-year mortality in COVID-19 is associated with patients' comorbidities rather than pneumonia severityLuca Novelli, Federico Raimondi, Greta Carioli, et al.
NEJM Evidence|February 6, 2024
Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia VeraTiziano Barbui, Alessandro Maria Vannucchi, Valerio De Stefano, et al.
Annals of Hematology|December 7, 2023
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomesTiziano Barbui, Alessandra Carobbio, Valerio De Stefano, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 21, 2021
Coffee consumption and gastric cancer: a pooled analysis from the Stomach cancer Pooling Project consortiumGeorgia Martimianaki, Paola Bertuccio, Gianfranco Alicandro, et al.
Pageof 5